# Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain

> **NCT00560183** · PHASE3 · COMPLETED · sponsor: **QRxPharma Inc.** · enrollment: 256 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Q8003 (morphine sulfate and oxycodone hydrochloride)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00560183
- **Lead sponsor:** QRxPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560183, "Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00560183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*